← Back to Clinical Trials
Recruiting NCT06407219

NCT06407219 Evaluating the Impacts of a Single Session of Robot Assisted Gait Training With a Trexo

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06407219
Status Recruiting
Phase
Sponsor University of Calgary
Condition Physical Disability
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2022-03-14
Primary Completion 2026-12

Trial Parameters

Condition Physical Disability
Sponsor University of Calgary
Study Type INTERVENTIONAL
Phase N/A
Enrollment 50
Sex ALL
Min Age 4 Years
Max Age N/A
Start Date 2022-03-14
Completion 2026-12
Interventions
Robot Assisted Gait Training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Early use of robotic gait trainers have shown many benefits, however why these benefits occur and how to maximize them is unknown. There are a few options for how a robotic gait trainer can be used, however, there is not much understanding of how these options impact rehabilitation and compensate for impairments. The investigators aim to evaluate the impacts of as single session of Trexo robotic gait training and the impact of different modes of the Trexo robotic gait trainer. The investigators will evaluate how the different settings impact things like physical activity, walking, brain activity, spasticity, and fatigue. Investigators will arrange for a familiarity and fitting session to start, so that study team members can fit the participant to the Trexo and so that participants can become familiar with the feeling of using the Trexo robotic gait trainer. After the initial fitting sessions, follow up sessions will be completed to evaluate different settings on the Trexo, for example in "endurance" mode (where the robot completes the movements for the participant) and in "strength" mode (where the robot requires some assistance from the participant). Investigators may also test different fitting settings, for example with and without the supportive seat in the Trexo. Only three visits are required (one fitting/familiarity session and two testing sessions), however participants and/or their families may choose to complete more testing sessions if they want to assess other aspects of the training. For example, if the first two testing sessions assessed physical activity, participants and their families may choose to return for further sessions to assess brain activity. The aim of the study is to determine how robot assisted gait training impacts rehabilitation and compensates for impairments, as well as to provide suggestions on how the robotic gait trainer might be improved or modified. This study is exploratory to find out more about how these robotic gait trainers, specifically the Trexo, impacts various aspects of rehabilitation.

Eligibility Criteria

Inclusion Criteria: * Able to fit into the Trexo robotic gait trainer (\<150 lbs., \<5'7"). * Has impaired ability to walk due to a neurological or muscular disorder. Exclusion Criteria: * \>150 lbs. * \>5'6" tall * Medical contraindication to weight bearing (ie. recent orthopedic surgery)

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology